Antiepileptic drug effects on mood and behavior: Molecular targets

被引:88
|
作者
Perucca, Piero [1 ]
Mula, Marco [2 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Amedeo Avogadro Univ, Div Neurol, Novara, Italy
关键词
Epilepsy; Antiepileptic drugs; Depression; Psychosis; Lacosamide; Retigabine; PLACEBO-CONTROLLED TRIAL; GENERALIZED ANXIETY DISORDER; PSYCHIATRIC ADVERSE EVENTS; MAJOR DEPRESSIVE DISORDER; BIPOLAR-I-DISORDER; BORDERLINE PERSONALITY-DISORDER; RELEASE CARBAMAZEPINE CAPSULES; POSTTRAUMATIC-STRESS-DISORDER; SEVERE MYOCLONIC EPILEPSY; GATED SODIUM-CHANNELS;
D O I
10.1016/j.yebeh.2012.09.018
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
With almost 100 years of clinical experience, antiepileptic drugs (AEDs) remain the mainstay of epilepsy treatment. They suppress epileptic seizures by acting on a variety of mechanisms and molecular targets involved in the regulation of neuronal excitability. These include inhibitory-GABAergic and excitatory-glutamatergic neurotransmission, as well as ion (sodium and calcium) conductance through voltage-gated channels. On the other hand, accruing evidence indicates that these mechanisms and targets are also implicated in the regulation of mood and behavior, which may explain why each AED is associated with specific psychotropic effects. These effects, however, cannot be explained solely on the basis of the known mode of action of each AED, and other mechanisms or targets are likely to be implicated. In this article, we review positive and negative effects of AEDs on mood and behavior, discuss putative underlying mechanisms, and highlight knowledge gaps which should be addressed in future studies. This article is part of a Special Issue entitled "The Future of Translational Epilepsy Research". (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:440 / 449
页数:10
相关论文
共 50 条